Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 30

Results For "Scientific"

1284 News Found

Almirall opens Shanghai hub to power dermatology innovation and China partnerships
Biopharma | March 14, 2026

Almirall opens Shanghai hub to power dermatology innovation and China partnerships

The move comes as China rapidly expands its capabilities in the pharmaceutical sector, particularly in licensing and drug development


Biogen unveils promising new data for Salanersen in kids with SMA
News | March 14, 2026

Biogen unveils promising new data for Salanersen in kids with SMA

Salanersen was generally well-tolerated, slowed neurodegeneration, and enabled functional gains


Single-use gloves misused across India, raising health risks
Healthcare | March 14, 2026

Single-use gloves misused across India, raising health risks

One task, one interaction, one pair, experts advocate


Punjab joins hands with Roche to roll out ‘NeuroSakhi’ for women with multiple sclerosis
Healthcare | March 12, 2026

Punjab joins hands with Roche to roll out ‘NeuroSakhi’ for women with multiple sclerosis

The NeuroSakhi initiative aims to close these gaps by strengthening awareness, building patient support networks and improving engagement between healthcare professionals, patients and caregivers across Punjab


FDA nod to first treatment for rare genetic brain disorder
Drug Approval | March 12, 2026

FDA nod to first treatment for rare genetic brain disorder

The approval comes after a systematic review of published literature


Roche shareholders back full slate of proposals, approve record dividend increase
News | March 11, 2026

Roche shareholders back full slate of proposals, approve record dividend increase

Dr Severin Schwan was re-elected as Chairman of the Board with 97.75% of the votes


EU unveils draft guidance to fast-track clinical trials during public health emergencies
Policy | March 09, 2026

EU unveils draft guidance to fast-track clinical trials during public health emergencies

The document, published under the Accelerating Clinical Trials in the EU (ACT EU) initiative, sets out how trials should be conducted when health emergencies disrupt normal research operations